oral semaglutide compounded for Weight Loss — Tablets free GLP Oral Semaglutide for Weight Loss

Overall, there is a crosstalk between cancer cells and the periprostatic adipose tissue, locally-produced adipokines support the development of the tumor microenvironment, and fatty acid-binding protein 4 (FABP4) released by adipocytes would constitute an energy source for tumor cell invasion (28, 30)

What qualifies as an HSA- or FSA-eligible expense

However, the landmark SURMOUNT-5 trial (published in mid-2025), which compared the two medications head-to-head, clarified the clinical reality: Total Weight Loss: Tirzepatide drives significantly greater total weight loss (averaging over 20%) compared to semaglutide (averaging roughly 14%)

Most participants were white, so more diversity could be important in future trials